Nath Bio-Genes India Ltd Q1 FY2022-23 net profit at Rs. 30.75 crores

Nath Bio-Genes (India) Limited has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 209.3897 crores during the period ended June 30, 2022 as compared to Rs. 27.9376 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 30.7564 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. -116.2877 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 16.18 for the period ended June 30, 2022 as compared to Rs. -61.19 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 209.3897 crs	₹27.9376 crs	649.49%
Net Profit	₹30.7564 crs	₹-116.2877 crs	126.45%
EPS	₹16.18	₹-61.19	126.44%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 209.3897 crores during the period ended June 30, 2022 as compared to Rs.215.1029 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.30.7564 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.44.9116 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.16.18 for the period ended June 30, 2022 as compared to Rs.23.63 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 209.3897 crs	₹215.1029 crs	-2.66%
Net Profit	₹30.7564 crs	₹44.9116 crs	-31.52%
EPS	₹16.18	₹23.63	-31.53%

Shares of Nath Bio-Genes (India) Limited was last trading in BSE at Rs. 178.45 as compared to the previous close of Rs. 178.25. The total number of shares traded during the day was 493 in over 24 trades.

The stock hit an intraday high of Rs. 179.70 and intraday low of 174.70. The net turnover during the day was Rs. 86846.00.

Source : Equity Bulls

Keywords

NathBioGenesIndia Q1FY23 ResultUpdate